United States · Funded startup

Who invested in Birch Biosciences

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Y Combinator: S22

Funding summaryUpdated 26 Oct 2026

$1.6Mraised across 1 round since 2023, from 1 source

Latest round
Grant, $1.6MFeb 2023
Investors
4
See who backed them

The rounds

  1. Feb 2023

Everyone who backed them

Y CombinatorAccelerator1round
Liquid 2 VenturesVC firm1round
Pioneer FundPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Birch Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Collaborative FundVC firmPer its own site
FundamentIncubatorPer its own site
IntegrityAcceleratorPer its own site

Quick answers about Birch Biosciences

Who invested in Birch Biosciences?

Birch Biosciences's investors include Y Combinator, National Science Foundation, Liquid 2 Ventures and Pioneer Fund.

How much has Birch Biosciences raised?

Birch Biosciences has raised $1.6M across 1 round since 2023.

When did Birch Biosciences last raise?

Birch Biosciences's most recent round was a Grant of $1.6M in Feb 2023.

What was Birch Biosciences's biggest round?

Its most recent round, $1.6M in Feb 2023, is also its largest on record.

Who backed Birch Biosciences first?

Birch Biosciences's first round on record, in Feb 2023, was backed by Y Combinator, National Science Foundation and Liquid 2 Ventures and 1 others.

What stage is Birch Biosciences at?

Birch Biosciences's latest named round is a Grant, in Feb 2023.

Where is Birch Biosciences based?

Birch Biosciences is based in the United States.

Companies like Birch Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.